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Abstract
Cystinuria is an aminoaciduria caused by mutations in the genes that encode the two sub-
units of the amino acid transport system b0,+, responsible for the renal reabsorption of cys-
tine and dibasic amino acids. The clinical symptoms of cystinuria relate to nephrolithiasis,
due to the precipitation of cystine in urine. Mutations in SLC3A1, which codes for the heavy
subunit rBAT, cause cystinuria type A, whereas mutations in SLC7A9, which encodes the
light subunit b0,+AT, cause cystinuria type B. By crossing Slc3a1-/- with Slc7a9-/- mice we
generated a type AB cystinuria mouse model to test digenic inheritance of cystinuria. The 9
genotypes obtained have been analyzed at early (2- and 5-months) and late stage (8-
months) of the disease. Monitoring the lithiasic phenotype by X-ray, urine amino acid con-
tent analysis and protein expression studies have shown that double heterozygous mice
(Slc7a9+/-Slc3a1+/-) present lower expression of system b0,+ and higher hyperexcretion of
cystine than single heterozygotes (Slc7a9+/-Slc3a1+/+ and Slc7a9+/+Slc3a1+/-) and give rise
to lithiasis in 4% of the mice, demonstrating that cystinuria has a digenic inheritance in this
mouse model. Moreover in this study it has been demonstrated a genotype/phenotype cor-
relation in type AB cystinuria mouse model providing new insights for further molecular and
genetic studies of cystinuria patients.
Introduction
Cystinuria is an inherited aminoaciduria caused by mutations in SLC7A9 and SLC3A1 that
encode for the two subunits b0,+AT and rBAT, respectively. Intracellular assembly of both sub-
units by a disulfide bridge form a heterodimer that is expressed in the apical membrane of epi-
thelial cells and is required for functional amino acid transport of system b0,+ [1]. The rBAT/
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b0,+AT heterodimer mediates Na+‐independent exchange of external cationic amino acids and
cystine with neutral amino acids [2]. This complex is responsible for>90% of cystine reabsorp-
tion in epithelial cells of the renal proximal tubule and small intestine [3,4]. Thus, system b0,+
malfunction causes an inadequate reabsorption of cystine and dibasic amino acids (lysine, argi-
nine and ornithine) triggering their urine hyperexcretion, the hallmark of cystinuria [5]. The
clinical symptoms of cystinuria are caused by cystine’s precipitation due to is poor solubility,
forming stones in the urinary tract that cause obstruction, infection and, ultimately, chronic
kidney disease in patients [6].
Cystinuria caused by mutations in SLC3A1 (rBAT) has an autosomal recessive inheritance
pattern (OMIM 600918) and mutations in SLC7A9 (b0,+AT) follows a partially autosomal
dominant inheritance pattern (OMIM 220100). The lack of a genotype/phenotype correlation
has led to propose a genetic classification for cystinuria defined as type A if mutations are
found in SLC3A1, type B if mutations are found in SLC7A9 and type AB when one mutation is
found in each gene [7]. To date, 1.6% of cystinuria patients with lithiasic phenotype have been
classified as type AB. In fact, all of these cases are carriers of three mutations implying a trialle-
lic genotype; that is, AAB and BBA types [8]. Obligate heterozygous type AB carriers were only
detected in 3 cystinuric patients’ relatives, showing mild cystine hyperexcretion (2 to 3-fold
higher than normal) although far below the range found in patients (>20-fold). In addition
these individuals have never shown cystine urolithiasis [9–11], thus they have not been classi-
fied as cystinuria patients [9–11]. As obligate type AB (double heterozygous) individuals who
develop cystinuria have not been found, digenic inheritance of cystinuria was ruled out.
To date, nearly 600 mutated alleles in SLC3A1 and over 400 in SLC7A9 have been reported
in patients from different countries [8]. Although 1–2% of all cases of renal lithiasis and 6–8%
of pediatric renal lithiasis were diagnosed as cystinuria patients [12], 13% of analyzed alleles of
cystinuria patients remain to be identified [8]. Mutations in non-explored regions of SLC3A1
and SLC7A9 could be responsible for the cystinuria phenotype in these unidentified cases.
Other possibility is that partial loss of function of both genes that cause cystinuria (i.e. poly-
morphisms, non-detected mutations or combination of both) might explain the remaining
cases with cystinuria phenotype. Mutations in other genes involved in cystinuria are unlikely
because, to our knowledge, genetic linkage to the two-cystinuria loci has not been excluded in
any of the genetically unexplained patients (M.Font-LLitjòs, M.Palacín and V.Nunes; unpub-
lished results).
Three mouse models of cystinuria have been described showing a clinical and biochemical
phenotype rather close to humans. Mutations in rBAT leading to Asp140Gly [13] or
Gly1232Ala [14] exhibited human type A cystinuria phenotype, and disruption of exon 3 to 9
of b0,+AT gene generates the features of human type B cystinuria [15]. By crossing both, type A
(Asp140Gly) and B (disruption of exon 3 to 9) mouse models, double heterozygous mice
(Slc3a1+/-Slc7a9+/-) have been generated to determine if partial loss of function of one of those
proteins and digenic inheritance of cystinuria-related genes could induce urolithiasis in mice.
Results
Viability of cystinuria type ABmice model
In order to unravel if cystinuria has a digenic inheritance, a second-generation breeding in
mixed background C3HeB/C57Bl6 cystinuria type AB mice model has been generated. After
obtaining 1152 mice, frequency of all 9 genotypes follows a normal pattern of Mendel's segre-
gation (Table 1) demonstrating that the absence of both subunits, which form system b0,+ and
causes cystinuria, are not lethal in this murine model. Body weight of either double mutant
(Slc7a9-/-Slc3a1-/-) nor double heterozygous mice (Slc7a9+/-Slc3a1+/-) does not show differences
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compared to both single mutant cystinuria mice models (Slc7a9-/-Slc3a1+/+ and Slc7a9+/
+Slc3a1-/-) (S1A Fig) and with wild type group (S1B Fig), respectively. Thus, a priori, the
absence of any of the subunits of the transport system b0,+ does not affect either viability nor
body weight in these animals.
Cystinuria phenotype characterization
Calculi formation has been analyzed by X-ray at 2, 5 and 8 months of age. Surprisingly, 5 out
of 138 double heterozygous mice (Slc7a9+/-Slc3a1+/-), which represent 4% of the animals, show
calculi formation. Despite of this low percentage of lithiasis, this result demonstrates that par-
tial loss of both subunits of system b0+ can cause a lithiasic phenotype (Table 2). Indeed, analy-
sis of calculi formation has shown that double mutants (Slc7a9-/-Slc3a1-/-) have both higher
lithiasis prevalence (Table 2) and higher stone size (Fig 1A), than single mutants (Slc7a9‐/
‐Slc3a1+/+ and Slc7a9+/+Slc3a1-/-). All double mutants presented calculi formation at 8 months
of age and almost 50% of them presented a severe phenotype exhibiting calculi in both kidneys
and bladder at the same time (Table 2). Concomitantly with the most severe lithiasic pheno-
type of the double mutant, kidney stones from animals with this genotype revealed a typical
Table 1. Inheritance percentage of F2 generation.
Slc7a9 Slc3a1 Male Observed Female Observed Expected
+/+ +/+ 48 7,6 42 7,9 6,3
+/+ +/- 121 19,3 109 20,5 12,5
+/+ -/- 35 5,6 38 7,1 6,3
+/- +/+ 94 15 86 16,2 12,5
+/- +/- 138 22 122 22,9 25
+/- -/- 62 9,9 48 9,0 12,5
-/- +/+ 41 6,5 30 5,6 6,3
-/- +/- 57 9,1 41 7,7 12,5
-/- -/- 24 3,8 16 3,0 6,1
TOTAL 620 532
Data from 1152 offspring obtained from 10 different couples of F2 double heterozygous progenitors. Male/Female: Number of animals of each genotype.
Observed: Percentage of newborn for each genotype. Expected: Percentage of segregation according to Mendel inheritance. No differences were found
analyzing data with Chi-square test (p-value = 0,98 comparing real and expected frequency).
doi:10.1371/journal.pone.0137277.t001
Table 2. Percentage of calculi formation and lithiasis prevalence.
Genotype Bladder Kidney % Lithiasis Bladder and kidney % Lithiasis in
bladder and both
kidneys
Slc7a9 Slc3a1 2m 5m 8m 2m 5m 8m 2m 5m 8m 2m 5m 8m 2m 5m 8m
+/- +/- 4/90 4/90 4/90 0/90 0/90 0/90 4 4 4 0/90 0/90 0/90 0 0 0
+/+ -/- 7/24 12/22 10/13 6/24 10/22 5/13 54 83 92 0/24 4/22 3/13 0 18 25
-/- +/+ 9/22 15/21 19/21 7/22 8/21 6/20 73 91 91 0/22 4/20 6/20 0 20 30
-/- -/- 7/22 16/22 8/13 5/22 5/20 11/13 55 73 100 0/22 5/20 6/13 0 25 46
Table shows the results of tracking the calculi formation by X-ray. Number of mice that have developed calculi in bladder, kidney or in both organs
(Bladder and kidney) at 2, 5 and 8 months of age (2m, 5m and 8m) are indicated (mice with calculi / mice studied). Percentages of mice with calculi (%
Lithiasis) and with simultaneous calculi formation (% Lithiasis in bladder and both kidneys) are indicated.
doi:10.1371/journal.pone.0137277.t002
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shape that has not been found yet in the other cystinuria mouse models. 12% of double
mutants (3 of 24 Slc7a9-/-Slc3a1-/- mice) showed renal calculi that filled the cavity of the renal
papilla acquiring a staghorn shape, which collapsed the kidney and led to renal failure (Fig 1B).
Hematoxylin/eosin stained sections of kidneys from the 9 genotypes were analyzed (Fig 2).
Necropsy and histopathology reveal that lithiasic kidney develops renal damage as glomerulo-
sclerosis, renal tubules dilatation and focal interstitial inflammation in different degrees. Histo-
logical results correlate to different parameters as permanence, quantity or size of the calculi
rather than to the genotype. Thereby, double homozygous mutants, which have more severe
lithiasic phenotype, present strongest renal damage (Fig 2 row C) comparing with single homo-
zygous mutants (Fig 2 row B). Single heterozygous mice, wild type and double heterozygous
mice, even with lithiasic phenotype; do not show kidney damage (Fig 2 row A). This observa-
tion could be explained by the small size of the calculi present in the double heterozygous
mutants, which could be detected by X-ray but impossible to extract during the necropsy
because, due to its small size, have been impossible to localize. Furthermore, in double hetero-
zygotes, stones have only been detected in bladder, never in kidneys (Fig 1C).
Urine hyperexcretion
In order to determine the function of system b0,+ amino acids content of 24h urine samples
have been analyzed. Double heterozygous mice, which showed calculi formation in 4% of the
cases, show slight differences in dibasic amino acids urine excretion compared with singles het-
erozygotes animals (Fig 3A, 3B and 3C) and hyperexcrete 5- and 2-fold cystine in urine com-
pared with single heterozygous mice (Fig 3D). Slc7a9 heterozygous mice are classified as non‐
type I cystinuria which hyperexcretes cystine and dibasic amino acids but does not show lithia-
sic phenotype [15]. Thus, double levels of cystine in urine could reach its solubilization thresh-
old [16], triggering calculi formation and explaining the 4% of lithiasis found in double
heterozygous mice (Table 2).
Fig 1. Characterization of lithiasic phenotype. A. Graph shows kidney calculi weight. Mean ± S.E.M of calculi weight (mg) of single mutants
(Slc7a9-/-Slc3a1+/+ and Slc7a9+/+Slc3a1-/-) and double mutant (Slc7a9-/- Slc3a1-/-) are represented. 5 to 7 calculi of male mice at 5 months of age were
weighted for each genotype. Student’s t-test is represented as * p‐<0,05 and ***p<0,001.B. Example of a staghorn calculi found in double mutant that fills
the whole medulla.C. Example of X-ray from a double heterozygous mouse (Slc7a9+/- Slc3a1+/-) where the balder stone is indicated with an arrow.
doi:10.1371/journal.pone.0137277.g001
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Surprisingly, double homozygous mutants (Slc7a9-/-Slc3a1-/-) show a slight decrease in cys-
tine hyperexcretion compared to both single homozygous mutants (Fig 4A). In the presence of
calculi, cystine is forming the stone(s) and there is less free cystine in urine. As lithiasis preva-
lence and size of stones in double homozygous mutants are higher than in both single homozy-
gous mice (Table 2), a significant part of the cystine might be forming the calculi. Therefore, it
is feasible that levels of cystine in urine show a tendency to decrease in the double mutants
compared to single mutants.
b0,+AT/ rBAT protein analysis
Western blot analysis of apical renal membranes was performed to test the presence/absence of
b0,+AT (Slc7a9) and rBAT (Slc3a1) subunits and confirm the correlation of amount of protein
versus genotypes. Double homozygous mutant (Slc7a9-/-Slc3a1-/-) did not show either b0,+AT
Fig 2. Histopathological studies of renal sections.Hematoxylin/eosine staining. Analysis were done in wild‐type mice (row A), single mutants (row B) and
double mutant (row C) mice. In B and C groups; only kidneys with calculi were analyzed. Column 1 shows glomerulus (G). A1: normal glomerulus;B1:
glomerulus with partial collapse of capillary loops;C1: glomerulus with global matrix increase. Column 2 shows interstitial inflammation (arrow) and tubular
atrophy.A2: normal tissue; B2: high level of interstitial inflammation;C2: interstitial inflammation and tubular atrophy. Column 3 shows renal tubules (t). A3:
normal renal cortex; B3: tubular atrophy in renal cortex; C3: tubular atrophy with lumen dilatation.
doi:10.1371/journal.pone.0137277.g002
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nor rBAT demonstrating that double mutant mice completely abolish the presence of both
subunits of system b0,+ (Fig 4A and 4B). Protein analysis also shows 10% of remaining rBAT/
b0,+AT heterodimer in renal brush-borders of Asp140Gly rBAT homozygous mutant (Slc7a9+/
+Slc3a1-/-) (Fig 4A, 4B and 4D). As rBAT mutant mouse model used in this study has a point
mutation not being a total knockout, this result demonstrates that some mutated rBAT reaches
the apical membrane conferring some system b0,+ activity to the renal cell. In contrast, ablation
of b0,+AT (Slc7a9-/-Slc3a1+/+) completely abolished the expression of the heterodimer (Fig 4B).
Additionally, the absence of b0,+AT shows the presence of another rBAT-associated subunit
forming a 120 kDa heterodimer (Fig 4A). Western blot of apical membranes in non-reducing
conditions of Slc7a9 homozygous knockout confirms, as co-immunopurification studies
described before [17], that all b0,+AT present in renal brush-border heterodimerizes with
rBAT, but not all rBAT forms heterodimers with b0,+AT.
Since rBAT antibody in non-reducing conditions detects both heterodimers, rBAT/b0,+AT
and rBAT/unknown light subunit, to assess the correct quantification of system b0,+ brush-bor-
der samples were analyzed using b0,+AT antibody (Fig 4B and 4C). This analysis shows a lower
Fig 3. Urine amino acid content.Mean±S.E.M. of urine amino acids (nmols amino acid/24hg) of arginine (A), ornithine (B), lysine (C) and cystine (D) from
3 months‐old male mice (n7 animals for each genotype) are represented. Student’s t-test is represented as * p<0,05; **p<0,01 and ***p<0,001. Bars
which represent double heterozygous (Slc7a9+/-Slc3a1+/-) and double mutants (Slc7a9‐-/-Slc3a1-/-) are filled in gray and black, respectively.
doi:10.1371/journal.pone.0137277.g003
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presence of the heterodimer (rBAT/b0,+AT) in renal apical membranes of the double heterozy-
gous mice (Slc7a9+/-Slc3a1+/-) comparing with both single heterozygous mutants (Slc7a9+/
+Slc3a1+/- and Slc7a9+/-Slc3a1+/+) (Fig 4C and 4D). Densitometric analysis shows that the pres-
ence of system b0,+ in renal apical membranes of double heterozygous mice is around 40%
lower than b0,+AT heterozygous mice (Fig 4D). Double heterozygous mice show lithiasis in 4%
of the mice at 8 months of age (Table 2) and higher cystine hyperexcretion than both single
heterozygous mice (Fig 3D), indicating a correlation between levels of rBAT/b0,+AT heterodi-
mer in brush-borders with both hyperexcretion and lithiasic phenotypes. Thus, lower quantity
of the rBAT/b0,+AT heterodimer entails higher levels of cystine in urine indicating a system
b0,+ malfunction, and eventually cystine lithiasis.
Fig 4. Western blot of brush‐border kidneymembranes. Protein analysis of rBAT and b0,+AT in kidney brush‐border membranes of different genotypes.
Fifty micrograms of protein were loaded in all lanes and run in non‐reducing conditions in 7% acrylamide SDS-page. Molecular mass standard (kDa) are
indicated. A. Antibodies against rBAT and β-actin were used and are indicated on the left side. Arrows from right side indicate the heterodimer (HT) and, as
well the oligomeric structure of 2 heterodimers (2xHT). Wild‐type (Slc7a9+/+ Slc3a1+/+), single mutants (Slc7a9+/+ Slc3a1-/- and Slc7a9-/- Slc3a1+/+), double
mutant (Slc7a9-/- Slc3a1-/-) and double heterozygous (Slc7a9+/- Slc3a1+/-) are shown.B and C. Antibodies against b0,+AT and β-actin were used and are
indicated on the left side. Arrows from right side indicate the rBAT/b0,+AT heterodimer (HT), the oligomeric structure of 2 heterodimers (2xHT) and a band
corresponding to a complex, variable among experiments, formed by the oligomerization of b0,+AT detached from rBAT artifact of brush-border extraction
and/or SDS-page conditions (*). (B) Wild type, single mutants, double mutant and double heterozygous mice are represented. (C) Wild type, double and both
single heterozygous (Slc7a9+/- Slc3a1+/+ and Slc7a9+/+ Slc3a1+/-) samples are shown.D. Graph representing the densitometry analysis of b0,+AT corrected
by β-actin of double and single heterozygous, rBAT mutant and double mutant samples compared to wild type. The mean of 3–4 independent western blot
analysis is represented.
doi:10.1371/journal.pone.0137277.g004
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Discussion
The scarce number of patients classified as obligate cystinuria type AB and the high percentage
(13%) of cystinuria patients that remain to be classified encouraged us to generate a cystinuria
type AB in vivomodel to analyze genotype/phenotype correlation and test the existence of possi-
ble digenia in cystinuria. Tracking the lithiasic phenotype by X-ray allowed us to detect calculi
formation in 4% of the double heterozygous mice (Slc7a9+/-Slc3a1+/-) (Table 2) demonstrating
that cystinuria has a digenic inheritance pattern in this mouse model. Concomitantly with the cal-
culi formation, double heterozygous mice have higher concentration of cystine in urine (Fig 3D)
besides lower amount of rBAT/b0,+AT heterodimer at the renal apical membrane (Fig 4C and
4D). These results are clear evidence that half-dose of both subunits of the transport system b0,+
decreases renal cystine reabsorption allowing the development of cystine urolithiasis. The low
lithiasis prevalence, as shown in double heterozygous mice, could be the explanation why digenic
inheritance pattern in cystinuria patients has not been detected yet. Nowadays, only 3 type AB
cases have been identified. Therefore, finding a stone former patient would not be easy to detect,
assuming a similar or lower percentage of lithiasis than the one observed in type AB mice (4%).
In addition, double heterozygous calculi have shown a very small size (Fig 1C) and have only
been found in mice bladders. So, due to the tiny size of the calculi and the low prevalence, digenic
cystinuria carriers could escape to the screening not being diagnosed as cystinuria patients and/or
misclassified as spontaneous urolithiasis cases if an urine cystine analysis content is not per-
formed. These results hint that patients who are carriers of double heterozygous mutations could
be classified as risk group to develop urolithiasis. Cystine hyperexcretion combined with external
factors such as water, protein or salt intake could trigger cystine precipitation and lithiasic pheno-
type [8]. For this reason, we strongly suggest to alert and inform the digenic carriers to follow the
cystinuria food and drink intake guideline to prevent the calculi manifestation [8].
Digenic inheritance of cystinuria in mice also could contribute to understand unclassified
cystinuria patients. As it has been demonstrated, partial loss of function of system b0,+ ends up
in full-blow cystinuria; and rBAT/b0,+AT heterodimer partial-dose could be caused by different
factors such as mutations in non-codifying regions or due to polymorphisms. Therefore, deeply
genetic study of unclassified cystinuria patients is recommended.
In humans, a cystinuria phenotype/genotype correlation was discarded because patients
sharing the same mutations show marked lithiasic phenotype and cystine hyperexcretion dif-
ferences [5,9]. Cystine crystals are formed when several conditions are met besides levels of
hyperexcreted cystine. It has been reported that many different external factors such as dietary
and lithiasis modulating genes all contribute to calculi formation [6]. Although all cystinuria
type AB generated mice share same life-style (diet and environment) and genetic background,
not all mice with same mutation formed calculi. Even so, prevalence and severity of lithiasic
phenotype differs between genotypes. It has been observed that prevalence and severity of lithi-
asis is increased in the double homozygotes (Slc7a-/-Slc3a1-/-) compared with the single ones
(Slc7a9-/-Slc3a1+/+ and Slc7a9+/+Slc3a-/-) (Table 2 and Fig 1). This strongest lithiasic phenotype
is in agreement with a recently reported patient which is carrier of 2 homozygous mutations,
one in each subunit, that shows excessively cystine hyperexcretion and an aggravated lithiasic
phenotype (very early calculi onset, within the first 14 month of age) [11]. In this line, protein
analysis of system b0,+ (Fig 4) revealed some interesting findings: 1) rBAT mutant mice are not
fully deficient in rBAT/b0,+AT heterodimer in renal apical membrane, 2) the existence of an
unknown light subunit that heterodimerizes with rBAT and 3) double mutant mice
(Slc7a9-/-Slc3a1-/-) completely abolish the presence of b0,+ system and also the rBAT/unknown
subunit heterodimer from renal apical membranes. There is no evidence of which could be the
transport activity of rBAT/unknown subunit, although the fractional excretion of cystine in
Digenia in Cystinuria Mouse Model
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Slc7a9-/- mice (i.e., complete ablation of system b0,+) is only 11%, attributing the remaining cys-
tine reabsorption to uncharacterized transport systems [18]. Considering that rBAT/unknown
subunit could play a role in cystine apical transport, the double mutant mice would have less
cystine renal reabsorption compared with both single mutants (Slc7a9-/-Slc3a1+/+ and Slc7a9+/
+Slc3a1-/-). Although urine amino acid content does not show differences in cystine content
between these genotypes (Fig 3D), because the main part is forming the calculi, differences in
the lithiasis severity (Table 2), a tendency in the kidney calculi size (Fig 1A) and the presence of
staghorn calculi (Fig 1B) have been detected. Thus, accordingly with our hypothesis, where
rBAT/unknown subunit could participate in cystine reabsorption besides system b0,+, the most
severe lithiasis phenotype has been found in double mutant mice, which completely abolish
both heterodimers.
Genotype/phenotype correlation is also found when comparing homozygous b0,+AT knock-
out (Slc7a9-/-Slc3a1+/+) and rBAT mutant (Slc7a9+/+Slc3a1-/-) mice. b0,+AT knockout has lost
completely system b0,+ transport activity and should have intact rBAT/unknown subunit het-
erodimer, whereas the rBAT mutant mice conserve approximately 10% of system b0,+ and
apparently lacks the heterodimer rBAT/unknown subunit (i.e., as resembling the double
mutant, which shows no presence of rBAT heterodimers in renal brush-borders (Fig 4A)). The
fact that lithiasis is more severe in b0,+AT knockout than in the rBAT mutant mice strongly
suggest that system b0,+ is more conspicuous for cystine reabsorption than the not yet defined
transport activity of the rBAT/unknown subunit. Alternatively, we cannot exclude the possibil-
ity that genetic factors could contribute in lithiasis phenotype. In type B cystinuria mice
(Slc7a9-/-Slc3a1+/+) lithiasic phenotype increases from 43% of calculi formation at 2-months of
age in the second filial generation to ~85% in the sixth filial generation obtained by intercross-
ing lithiasic mice in pure C57Bl/6 background (L.Feliubadaló, M.Palacín and V.Nunes; unpub-
lished results). In fact, lithiasis percentage of mice with same mutation varies among mice
strains, such as Slc3a1D140G mouse line in C3HeB pure background that shows 100% of calculi
formation [13] whereas in a mixed C57Bl6/J-C3H background is 90% (Table 2); being another
evidence that calculi formation could vary due to the genetic background itself. Thus, genetic
factors might affect lithiasis differences between genotypes. As this study has been performed
using a mixed genetic background (C57Bl6/J-C3H), genes contiguous with both mutations
could be accidentally slanted in either (Slc7a9-/-Slc3a1+/+) or (Slc7a+/+Slc3a1-/-) mice. It means
that genes adjacent to Slc7a9 are manly in C57Bl6/J background in the b0,+ AT knockout mice
meanwhile in rBAT mutant mice, genes bordering Slc3a1 pertain to C3H strain. Lithiasis mod-
ulating genes responsible for cystine calculi formation are unknown and its identification using
cystinuria mouse models is in progress.
Summarizing, generation and characterization of type AB cystinuria mouse model exhibited
a digenic inheritance where 4% of double heterozygous mice (Slc7a9+/-Slc3a1+/-) present lithiasis
phenotype. Moreover, analysis of the heterodimer in renal apical membrane of double and sin-
gle mutants provided more information of the molecular basis of cystinuria. In this study the
impact of a genetic factor, in addition to the mutations in the transport system b0,+, that could
modulate lithiasis prevalence and severity was confirmed. Indeed, results shown in this work
suggest that rBAT/unknown subunit heterodimer could play a role in renal cystine reabsorp-
tion. Generation of the type AB cystinuria mice provide a powerful tool for identification of
both lithiasis modifiers genes and the unknown light subunit that heterodimerizes with rBAT.
Methods
All protocols used in this study were reviewed and approved by the Institutional Animal Care
and Use Committee at IDIBELL in a facility accredited by the Association for the Assessment
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and Accreditation of Laboratory Animal Care International (AALAC) (B-9900010/3866). Mice
procedures were designed and done according with the highest scientific, humane, and ethical
principles.
Mouse model
Cystinuria type A and B mouse models were inter-crossed to generate cystinuria type AB
model. Slc7a9 knockout mice in C57BL/6J pure background [15] were crossed with Slc3a1D140G
mouse line in C3HeB pure background [13] obtaining a F1 generation in a mixed C57Bl6/
J-C3H genetic background. Double heterozygous mice (Slc7a9+/- Slc3a1+/-) were backcrossed
obtaining 620 mice of F2 generation with the 9 expected genotypes. At the end of each proce-
dure mice were euthanized in a CO2 chamber. To perform all experiments described in this
study only male mice have been analyzed because previous work using cystinuria mouse mod-
els [13,15] evidenced that there is no reason to suspect that results will differ between genders.
Genotyping
DNA extraction was performed from tail biopsy. Tail samples were incubated at 56°C ON with
0.4mg/mL of Proteinase K in lysis buffer (10mM Tris pH8.0, 100mMNaCl, 10mM EDTA
pH8.0, 0.5% SDS). DNA was precipitated using isopropanol and resuspended in DNAse-free
water. Slc7a9 was genotyped as published in [15]. To genotype Slc3a1 point mutation, PCR
conditions were 98°C(3’) [98°C(25”), 58°C(2’), 72°C(3’)]x30C 72°C(1’) using both primers,
For:CCGTGGTTTCCGTGTTCCTG and Rev:GCTTGCTGACTTCTGCTGCG. Product of rBAT
PCR was purified with QIAquick PCR Purification Kit (Quiagen) prior to sequencing using Big
Dye system (Life technologies) and reverse primer (Rev).
Urine amino acid content
Six mice of each genotype were kept in metabolic cages to collect 24h urine samples and amino
acids content was analyzed. Urine samples were diluted with 0.3M LiOH to solubilize possible
cystine crystals and NorLeucine (2000μM) was added as an internal control. Urine samples
were dried and resuspended with lithium citrate Loading Buffer pH 2.20 (Biochrom Ltd.).
Quantitative analysis of amino acids was performed by chromatographic separation by cation‐
exchange chromatography followed by post‐column derivatization with ninhydrin and UV
detection in an amino acid analyzer (Biochrom Ltd.). The amount of amino acids were identi-
fied according to the retention times of corresponding standards. Amount of amino acids were
calculated by internal standard NorLeucine and the standards, and normalized by the volume
of the analyzed sample.
Calculi detection
Cystine calculi in the urinary system were detected by X‐ray radiography (at 28kV, 16 mAs)
using a Senima HF mammography apparatus [19]. Mice were under isofluorane anesthesia.
Mice of each genotype were X-rayed at 2, 5 and 8 months of age.
Eosin/Hematoxylin staining
2 random paraffinized kidney tissue sections of 6 mice from each genotype were used for histo-
pathology analysis. Slides were stained with 0.1% Mayers Hematoxylin and 0.5% Eosin solu-
tions. Glomerular, tubular, interstitial and vascular lesions were scored by a nephropathologist
based on a 4-tier system (0: absent, 1: mild, 2: moderate, 3: severe) similar to the one normally
used to ascertain human kidney allograft lesions.
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Apical membranes (brush‐borders) Western blot
Apical membranes from 5 single mouse kidneys from each genotype mice were extracted fol-
lowing published protocol [20]. In order to detect the presence of the heterodimer [b0,+AT
(37kDa) + rBAT(90kDa)] (120kDa), all SDS-polyacrylamide gels were run in the absence of
reducing agents such as DTT or β-Mercaptoethanol to avoid heterodimer’s disruption. Both
rBAT and b0,+AT were rabbit polyclonal antibodies against mouse proteins produced in our
laboratory [17]. Antibodies were hybridized overnight at 4°C using 1/1000 dilution in 1% of
skimmed milk. Protein detection was done by ECL (GE Healthcare) reaction and film exposure
(FujiFilm). Densitometric analysis was done using Image J software. Statistical analysis per-
formed was the unpaired Student’s t-test using GraphPad Prism 4.0 software.
Supporting Information
S1 Fig. Graph of body weight. A. Body weight at different months of 8–10 single homozygous
mice (Slc7a9‐/‐ Slc3a1+/+ and Slc7a9+/+Slc3a1‐/‐, respectively) and 7 double mutants (Slc7a9‐/‐
Slc3a1-/-). B. Graph of body weight at different months of 10 wild type mice and 12 double het-
erozygous.
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